The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient Sample

• Published in: Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2018-01, Vol.18 (1), p.74-77.e1
• Main Authors: Del Prete, Christopher, Kim, Taeha, Lansigan, Frederick, Shatzel, Joseph, Friedman, Harley
• Format: Article
• Language: English
• Subjects: CVA; Female; Hematologic malignancy; History, 21st Century; Hospitalization; Hospitalized patients; Humans; Leukemia, Myeloid, Acute - complications; Leukemia, Myeloid, Acute - pathology; Male; Outcomes; Patient Admission; Stroke - epidemiology; Stroke - etiology; Stroke - pathology
• ISSN: 2152-2650; 2152-2669
• DOI: 10.1016/j.clml.2017.09.008

Acute leukemia predisposes patients toward the development of stroke. The latter, although devastating clinically, has been infrequently studied. Our study, using the 2012 National Inpatient Sample, found a 50-fold increase in the risk of stroke as compared with all inpatient admissions with a corresponding 5.5-fold increased risk of mortality. Significant risk factors for the development of stroke included urinary tract infection, hypernatremia, and acute renal failure. Acute leukemia is known to confer an elevated risk of both hemorrhagic and thrombotic complications, but the development of stroke in this population is poorly characterized. This study assesses clinical and epidemiologic factors in a population of inpatients with acute myeloid leukemia (AML) and stroke. Using the 2012 National Inpatient Sample, demographic and clinical data including age, gender, race, length of stay, in-hospital procedures, discharge diagnosis, disposition, and mortality incidence were extracted. Of 7,296,968 admissions, 10,984 patients with active AML were analyzed. Of these, 65 patients had a concomitant cerebrovascular accident (CVA) (hemorrhagic or ischemic). There was a 50-fold increase in the risk of stroke in patients with active AML compared with all admissions. Patients with AML and CVAs were found to have significantly higher inpatient mortality than for all admitted patients with stroke (36.9% vs. 6.7%; odds ratio, 5.5; 95% confidence interval, 2.3-8.8; P < .0001). Multivariate logistic regression, after controlling for confounding variables, identified acute renal failure with tubular necrosis, hypernatremia, urinary tract infection, and secondary thrombocytopenia as significant predictors of stroke. Patients with AML have an elevated risk of CVA compared with all inpatients, and mortality in this population is high. Better characterization of risk factors of stroke in this vulnerable population is still needed.